Qube Research & Technologies »

Mural Oncology shares owned by Qube Research & Technologies

Quarter-by-quarter ownership of Mural Oncology (MURA) shares owned by Qube Research & Technologies from 13F filings

Historical chart of Qube Research & Technologies investment in Mural Oncology

Tip: Access up to 7 years of quarterly data

All positions including Mural Oncology held by Qube Research & Technologies consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mural Oncology by Qube Research & Technologies

Quarter filed Position value Share count Share price at filing
2024-03-31 $38k 7.7k 4.89

More positions owned by Qube Research & Technologies

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Apple (AAPL)
Meta Platforms Cl A (META)
NVIDIA Corporation Call Option (NVDA)
Microsoft Corporation (MSFT)
Amazon Call Option (AMZN)
Visa Com Cl A (V)
Wal-Mart Stores (WMT)
Johnson & Johnson Call Option (JNJ)
Oracle Corporation (ORCL)
Tesla Motors Call Option (TSLA)
Hess (HES)
McDonald's Corporation Put Option (MCD)
Amgen Call Option (AMGN)
S&p Global Call Option (SPGI)

View all positions for Qube Research & Technologies

Top funds holding Mural Oncology

Armistice Capital
Westfield Capital Management Company
BlackRock
Vanguard Group
Verition Fund Management
Solas Capital Management
Alta Fundamental Advisers
Newtyn Management
Prosight Management
Geode Capital Management
PRIMECAP Management Company
Baker Bros. Advisors
Sonic GP
Nuveen Asset Management
Squarepoint Ops

View all funds holding Mural Oncology